168 related articles for article (PubMed ID: 37120858)
21. Bayesian adaptive basket trial design using model averaging.
Psioda MA; Xu J; Jiang Q; Ke C; Yang Z; Ibrahim JG
Biostatistics; 2021 Jan; 22(1):19-34. PubMed ID: 31107534
[TBL] [Abstract][Full Text] [Related]
22. A Bayesian basket trial design that borrows information across strata based on the similarity between the posterior distributions of the response probability.
Fujikawa K; Teramukai S; Yokota I; Daimon T
Biom J; 2020 Mar; 62(2):330-338. PubMed ID: 31608505
[TBL] [Abstract][Full Text] [Related]
23. Flexible Bayesian subgroup analysis in early and confirmatory trials.
Bunn V; Liu R; Lin J; Lin J
Contemp Clin Trials; 2020 Nov; 98():106149. PubMed ID: 32942055
[TBL] [Abstract][Full Text] [Related]
24. Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials.
Berry SM; Broglio KR; Groshen S; Berry DA
Clin Trials; 2013 Oct; 10(5):720-34. PubMed ID: 23983156
[TBL] [Abstract][Full Text] [Related]
25. rBMA: A robust Bayesian Model Averaging Method for phase II basket trials based on informative mixture priors.
Wang X; Wei W
Contemp Clin Trials; 2024 May; 140():107505. PubMed ID: 38521384
[TBL] [Abstract][Full Text] [Related]
26. RoBoT: a robust Bayesian hypothesis testing method for basket trials.
Zhou T; Ji Y
Biostatistics; 2021 Oct; 22(4):897-912. PubMed ID: 32061093
[TBL] [Abstract][Full Text] [Related]
27. An adaptive biomarker basket design in phase II oncology trials.
Liu S; Takeda K; Rong A
Pharm Stat; 2023 Jan; 22(1):128-142. PubMed ID: 36163614
[TBL] [Abstract][Full Text] [Related]
28. Increasing the efficiency of oncology basket trials using a Bayesian approach.
Liu R; Liu Z; Ghadessi M; Vonk R
Contemp Clin Trials; 2017 Dec; 63():67-72. PubMed ID: 28629993
[TBL] [Abstract][Full Text] [Related]
29. A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulations.
Asano J; Hirakawa A
Pharm Stat; 2020 Nov; 19(6):975-1000. PubMed ID: 32779393
[TBL] [Abstract][Full Text] [Related]
30. Basket trials in oncology: a systematic review of practices and methods, comparative analysis of innovative methods, and an appraisal of a missed opportunity.
Kasim A; Bean N; Hendriksen SJ; Chen TT; Zhou H; Psioda MA
Front Oncol; 2023; 13():1266286. PubMed ID: 38033501
[TBL] [Abstract][Full Text] [Related]
31. Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses.
Zhang J; Lin R; Chen X; Yan F
Clin Trials; 2024 Jun; 21(3):308-321. PubMed ID: 38243401
[TBL] [Abstract][Full Text] [Related]
32. Bayesian and frequentist approaches to sequential monitoring for futility in oncology basket trials: A comparison of Simon's two-stage design and Bayesian predictive probability monitoring with information sharing across baskets.
Kaizer A; Zabor E; Nie L; Hobbs B
PLoS One; 2022; 17(8):e0272367. PubMed ID: 35917296
[TBL] [Abstract][Full Text] [Related]
33. Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trials.
Jiang L; Nie L; Yan F; Yuan Y
Contemp Clin Trials; 2021 Aug; 107():106460. PubMed ID: 34098036
[TBL] [Abstract][Full Text] [Related]
34. Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial.
Turner RM; Turkova A; Moore CL; Bamford A; Archary M; Barlow-Mosha LN; Cotton MF; Cressey TR; Kaudha E; Lugemwa A; Lyall H; Mujuru HA; Mulenga V; Musiime V; Rojo P; Tudor-Williams G; Welch SB; Gibb DM; Ford D; White IR;
BMC Med Res Methodol; 2022 Feb; 22(1):49. PubMed ID: 35184739
[TBL] [Abstract][Full Text] [Related]
35. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
Ji Z; Lin J; Lin J
J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
[TBL] [Abstract][Full Text] [Related]
36. Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analyses.
Pan J; Bunn V; Hupf B; Lin J
J Biopharm Stat; 2022 Jul; 32(4):613-626. PubMed ID: 35737650
[TBL] [Abstract][Full Text] [Related]
37. A win ratio-based framework to combine multiple clinical endpoints in exploratory basket trials.
Zhang P; Li XN
J Biopharm Stat; 2024 Mar; 34(2):251-259. PubMed ID: 38252040
[TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
39. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
Harun N; Liu C; Kim MO
Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
[TBL] [Abstract][Full Text] [Related]
40. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
